Editorial Board
Editor-in-Chief
Aung Naing, MD, FACP
Professor, Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Editorial Board Members
Karen Autio, MD, MSc
Assistant Attending, Genitourinary Oncology Service and Early Drug Development Service, Memorial Sloan Kettering Cancer Center, New York, NY
Jyoti Bajpai, MD
Professor, Department of Medical Oncology, Tata Memorial Centre, Parel, Mumbai, India
Mehmet Asim Bilen, MD
Associate Professor and Director, Genitourinary Medical Oncology Program, Emory University, Atlanta, GA, USA
Helen Chen, MD
Senior Investigator and Medical Officer, Associate Chief, Investigational Drug Branch, Cancer Therapy Evaluation Program (CTEP), National Cancer Institute, Bethesda, MD, USA
Naval Daver, MD
Associate Professor, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Gerald Falchook, MD, MS
Director, Drug Development Unit, Sarah Cannon Research Institute at HealthONE, Denver, CO, USA
Aaron Goodman, MD
Associate Professor, Division of Blood and Marrow Transplantation, University of California, San Diego School of Medicine, San Diego, CA, USA
Joud Hajjar, MD, PhD, MS
Associate Professor and Service Chief, Adult Allergy and Immunology, Division of Immunology, Allergy, and Rheumatology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA
Rebecca Harrison, MD
BC Cancer, Vancouver, BC, Canada
Sungjune Kim, MD, PhD
Departments of Radiation Oncology and Immunology, H. Lee. Moffitt Cancer Center & Research Institute; Assistant Professor, Department of Oncologic Sciences, University of South Florida, Tampa, FL, USA
Matthew Krebs, MD
Clinical Senior Lecturer, Division of Cancer Sciences, Faculty of Biology, Medicine, and Health, The University of Manchester; Consultant in Medical Oncology, Experimental Cancer Medicine Team, The Christie NHS Foundation Trust, Manchester, UK
Vladimir Lazar, MD, PhD
Chief Scientific and Operating Officer, Worldwide Innovative Network (WIN) Association - WIN Consortium, Villejuif, France
Yisheng Li, PhD
Professor, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Chia-Chi Lin, MD, PhD
Director of Phase 1 Center, Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan
Sewanti Limaye MS, MBBS, MD
Department of Clinical and Translational Research Oncology, Department of Precision Oncology, Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, India
Sanam Loghavi, MD
Assistant Professor, Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Herbert Loong, MD
Clinical Associate Professor, Department of Clinical Oncology; Deputy Medical Director, Phase 1 Clinical Trials Centre, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China
Juanita Lopez, MD
Consultant in Medical Oncology, Drug Development Phase 1 Unit, Royal Marsden Hospital and The Institute of Cancer Research, London, UK
Christophe Massard, MD
Department of Drug Development (DITEP), Gustave Roussy, Villejuif, France; Centre Eugène Marquis, Rennes, France; INSERM U1030, Université Paris-Saclay, Gif-sur-Yvette, France
Gil Morgan, MD
Department of Oncology, Skåne University Hospital, Lund, Sweden
Paolo Nuciforo, MD
Principal Investigator, Molecular Oncology Group, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron University Hospital, Barcelona, Spain
Haeseong Park, MD MPH
Co-Director, Developmental Therapeutics (Phase I) Program, Division of Oncology, Alvin J Siteman Cancer Center, Washington University in Saint Louis, St. Louis, MO, USA
Naveen Pemmaraju, MD
Associate Professor, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Jordi Rodon Ahnert, MD
Associate Professor, Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Christian Rolfo, MD
Associate Director of Clinical Research, Center for Thoracic Oncology, The Tisch Cancer Institute, Mount Sinai Health System; Professor, Icahn School of Medicine at Mount Sinai, New York, NY, USA
Patricia Roxburgh, MD
Senior Clinical Lecturer, Experimental Therapeutics, Institute of Cancer Sciences, University of Glasgow; Beatson West of Scotland Cancer Centre, Glasgow, Scotland, UK
Ajay Sheshadri, MD
Associate Professor, Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Bettzy Stephen, MD
Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Shannon N. Westin, MD, MPH, FACOG
Director, Early Drug Development, Gynecologic Oncology and Reproductive Medicine, The University of Texas UT MD Anderson Cancer Center, Houston, TX, USA
Eddy Yang, MD, PhD
Professor and Markey Cancer Foundation Chair, Department of Radiation Medicine, Markey Cancer Center, University of Kentucky College of Medicine, Lexington, KY, USA
